About Singletto
Singletto is a private company based in Seattle, Washington. It has reported $10,952,720 raised in six offerings on Form D since October 2020. Its chief executive is John Bjornson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 5, 2026 | $100,000of $10.0M target | 1 | $100K | DebtRule 506(b) | Form D ↗ |
| Apr 15, 2025 | Apr 28, 2025 | $10,462,720of $13.3M target | 80 | $130K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 17, 2024 | Jan 19, 2024 | $65,000of $10.0M target | 1 | $65,000 | DebtRule 506(b) | Form D ↗ |
| May 5, 2023 | May 8, 2023 | $200,000of $5.0M target | 2 | $100K | DebtRule 506(b) | Form D ↗ |
| Aug 6, 2021 | Aug 6, 2021 | $50,000of $5.0M target | 1 | $50,000 | DebtRule 506(b) | Form D ↗ |
| Sep 22, 2020 | Oct 6, 2020 | $75,000of $1.5M target | 3 | $25,000 | DebtRule 506(b) | Form D ↗ |
| Total, six offerings | $10,952,720 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Singletto's Form D filed Mar 5, 2026.
Michael Butler
Board Member
Thomas Lendvay
Chief Medical Officer and director
Also an executive officer and director at Tend Health.
Sources
- SECSingletto Inc. filing history
- CompanyContact
- CompanyProGear + Oxafence Masks Receive FDA Clearance and Launch in U.S. Healthcare
- CompanyTeam
- CompanyAbout